Pruritus precipitated by hydroxyethyl starch: a review

被引:64
作者
Bork, K [1 ]
机构
[1] Univ Mainz, Dept Dermatol, D-55131 Mainz, Germany
关键词
hetastarch; pharmacoepidemiology; pruritus; quality of life; safety; tissues;
D O I
10.1111/J.1365-2133.2004.06272.X
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Hydroxyethyl starch (HES) is widely used for fluid management in broad populations of patients, particularly in the surgery and intensive care settings. Pruritus, often manifested as pruritic crises, is increasingly being recognized as a common major adverse effect of HES ad-ministration. This iatrogenic form of pruritus is frequently severe and protracted with a serious negative impact on patient quality of life, including sleep disturbance, disruption of daily routine and mental distress. Such pruritus is generally refractory to available therapies and can persist for up to 12-24 months. All currently clinically available HES solutions entail the risk of pruritus, including those of diverse molecular weights and substitutions. Although dose dependent, HES-induced pruritus nevertheless can often be provoked by relatively low routine doses. The pathophysiological. basis for pruritus is the widespread tissue deposition of HES, prominently in macrophages. HES tissue deposits are long lasting and sometimes massive. Usually several weeks elapse between HES exposure and the onset of pruritus. Consequently, it is important to inquire about prior HES exposure in the diagnostic evaluation of pruritus sine materia. Awareness about the scope of the pruritus problem needs to increase among physicians administering HES. Well-designed clinical outcome studies are needed to assess more fully the incidence, dose dependency and mechanisms of pruritus with particular HES solutions.
引用
收藏
页码:3 / 12
页数:10
相关论文
共 71 条
  • [11] INTRAVASCULAR PERSISTENCE OF HYDROXYETHYL STARCH IN MAN
    BOON, JC
    JESCH, F
    RING, J
    MESSMER, K
    [J]. EUROPEAN SURGICAL RESEARCH, 1976, 8 (06) : 497 - 503
  • [12] Assessment of the safety and tolerance of 6% hydroxyethyl starch (200/0.5) solution: A randomized, controlled epidemiology study
    Bothner, U
    Georgieff, M
    Vogt, NH
    [J]. ANESTHESIA AND ANALGESIA, 1998, 86 (04) : 850 - 855
  • [13] Early and late histamine release induced by albumin, hetastarch and polygeline: some unexpected findings
    Celik, I
    Duda, D
    Stinner, B
    Kimura, K
    Gajek, H
    Lorenz, W
    [J]. INFLAMMATION RESEARCH, 2003, 52 (10) : 408 - 416
  • [14] Worsening of hepatic dysfunction as a consequence of repeated hydroxyethylstarch infusions
    Christidis, C
    Mal, F
    Ramos, J
    Senejoux, A
    Callard, P
    Navarro, R
    Trinchet, JC
    Larrey, D
    Beaugrand, M
    Guettier, C
    [J]. JOURNAL OF HEPATOLOGY, 2001, 35 (06) : 726 - 732
  • [15] Cox NH, 1996, BRIT J DERMATOL, V134, P353
  • [16] Hydroxyethyl starch does not impair immediate renal function in kidney transplant recipients: a retrospective, multicentre analysis
    Deman, A
    Peeters, P
    Sennesael, J
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 (06) : 1517 - 1520
  • [17] PRURITUS AFTER TREATMENT WITH HYDROXYETHYL STARCH FOR SUDDEN SENSORINEURAL HEARING-LOSS
    DESLOOVERE, C
    KNECHT, R
    [J]. LARYNGO-RHINO-OTOLOGIE, 1995, 74 (08) : 468 - 472
  • [18] DETTORI N, 2003, TATM, V5, P401
  • [19] ACCUMULATION OF HYDROXYETHYL STARCH (HES) IN THE LIVER OF PATIENTS WITH RENAL-FAILURE AND PORTAL-HYPERTENSION
    DIENES, HP
    GERHARZ, CD
    WAGNER, R
    WEBER, M
    JOHN, HD
    [J]. JOURNAL OF HEPATOLOGY, 1986, 3 (02) : 223 - 227
  • [20] Recent developments in European colloid solutions
    Dieterich, HJ
    [J]. JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2003, 54 (05): : S26 - S30